Related Experiment Video
Updated: Jun 29, 2026

Introducing a Gene Knockout Directly Into the Amastigote Stage of Trypanosoma cruzi Using the CRISPR/Cas9 System
Published on: July 31, 2019
Candimine as a natural scaffold for targeting squalene synthetase in Trypanosoma cruzi: insights from computational
Antonio Viayna1,2, Javier E Ortiz3, Frederick Schosinsky4
1Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona (UB), 08028, Barcelona, Spain.
Abstract:
Chagas disease (CD), caused by the kinetoplastid protozoan Trypanosoma cruzi, remains a major neglected tropical illness with limited therapeutic options. Natural products have historically provided structurally diverse scaffolds that serve as privileged templates in medicinal chemistry. Candimine (Cnd), an alkaloid isolated from Hippeastrum escoipense (Amaryllidaceae), has recently emerged as a promising compound with activity against T. cruzi. Although its antiparasitic effects are well documented, the precise molecular targets of Cnd have not been fully defined. The aim of this study was to perform a structure‑based molecular modeling analysis to investigate the direct interaction between candimine and key proteins essential for the survival of T. cruzi. The molecular docking and dynamics simulations revealed favorable interactions between Cnd and T. cruzi squalene synthetase (TcSQS), consistent with previously reported in vitro findings. Docking and simulation analyses showed that Cnd interacts favorably with this target, supporting a mechanism consistent with previous in vitro trypanocide activities. This is the first report to explore potential molecular mechanisms of action, offering new insights into TcSQS as a plausible target and positioning Cnd as a promising natural scaffold for developing next-generation therapies for CD.
